🌟Dr. Eve Nakabembe Vaccines in HIV context, Women Researcher AwardšŸ†

Ā  Doctorate at Makerere University College of Health Sciences, Uganda

Dr. Eve Nakabembe is a highly qualified and experienced Medical Doctor, specializing in Obstetrics and Gynecology/Maternal Child Health/Maternal Vaccines. Currently serving as a Senior Obstetrician/Gynecologist, Lecturer, and Clinical Researcher at Makerere University College of Health Sciences in Uganda, Dr. Nakabembe’s career is characterized by a commitment to women’s health and innovative research in maternal vaccines.

Author Metrics:

Citations:

  • Count: 78 citations
  • Explanation: Dr. Nakabembe’s publications have been cited 78 times by other researchers.

Documents:

  • Count: 8 documents
  • Explanation: Dr. Nakabembe has authored 8 scholarly documents, which include journal articles, conference papers, or other research outputs.

h-index:

  • Value: 3
  • Explanation: The h-index of 3 indicates that Dr. Nakabembe has published 3 papers that have each been cited at least 3 times.

Connect to:

ORCID Profile:

Scopus Profile

These metrics collectively provide a snapshot of Dr. Nakabembe’s academic influence, productivity, and the reception of her work within the scholarly community. They are commonly used in bibliometrics to assess and compare the research impact of scientists and scholars.

Education:

Dr. Nakabembe holds various academic qualifications, including a Bachelor of Medicine and Bachelor of Surgery from MUST Uganda (2003), MMed in Obstetrics and Gynecology/Research from Mbarara University of Science and Technology (2008), a Diploma in Sexual Reproductive Health and Rights from LU-Sweden (2009), and an MPhil in Vaccinology and Immunology from St George’s University of London, UK (2022). She is currently pursuing a Ph.D. as a Clinical Research Fellow at St George’s University of London.

Research Focus:

Dr. Nakabembe’s primary research focus is in the field of maternal vaccines. As the Ugandan Technical Lead and Principal Investigator for the WoMANPOWER maternal vaccine Randomized Clinical Trial, she plays a pivotal role in advancing knowledge and interventions for the health and well-being of pregnant women and their newborns.

Professional Journey:

With a career spanning from 2003 to the present, Dr. Nakabembe has held significant positions, including Director of the Mother Baby Friendly Hospital Initiative (MBFHI), Academic Coordinator for Save the Mothers program, and various roles at Uganda Christian University and Mbarara University of Science and Technology. Her diverse roles include clinical practice, teaching, and leadership, demonstrating a holistic approach to maternal and child health.

Publications Top Noted & Contributions:

Dr. Nakabembe has contributed significantly to academic literature with several publications. Notable works include studies on the safety and immunogenicity of pertussis-containing vaccines for HIV-infected pregnant women, strengthening maternal and child health responses to Ebola outbreaks, and advocating for vaccinating adolescent girls against COVID-19 in resource-limited settings.

Title: “The safety and immunogenicity of vaccines administered to pregnant women living with HIV: a systematic review and meta-analysis”

  • Journal: eClinicalMedicine (2024-03)
  • DOI: 10.1016/j.eclinm.2024.102448
  • Contributors: Eve Nakabembe, Jo Cooper, Kyle Amaral, Valerie Tusubira, Yingfen Hsia, Bahaa Abu-Raya, Musa Sekikubo, Annettee Nakimuli, Manish Sadarangani, Kirsty Le Doare

Title: “A case for vaccinating adolescent girls for protection against COVID-19 during pregnancy and childbirth in resource-limited settings [version 1; peer review: 1 approved, 1 approved with reservations]”

  • Journal: Gates Open Research (2023-01-30)
  • DOI: 10.12688/gatesopenres.13777.1
  • Contributors: Helena Blakeway, Lauren Hookham, Eve Nakabembe, Angela Koech, Asma Khalil, Shamez Ladhani, Marleen Temmerman, Kirsty Le Doare, Blakeway Helena, Blakeway Helena et al.

Title: “The safety and immunogenicity of a combined pertussis containing vaccine Tdap for HIV infected pregnant women and their newborns (WoMANPOWER) – A study protocol for a randomized clinical trial [version 1; peer review: 1 approved]”

  • Journal: Wellcome Open Research (2022-05-17)
  • DOI: 10.12688/wellcomeopenres.17749.1
  • Contributors: Eve Nakabembe, Bahaa Abu-Raya, Mary Kyohere, Valerie Tusubira, Alexander Amone, Lydia Nakibuuka, Madeleine Cochet, Annettee Nakimuli, Merryn Voysey, Andrew Gorringe et al.

Title: “Indirect effects of COVID-19 on maternal, neonatal, child, sexual and reproductive health services in Kampala, Uganda”

Title: “Relative impact of pre-eclampsia on birth weight in a low resource setting: A prospective cohort study”

Dr. Eve Nakabembe’s diverse research interests, including maternal vaccines, COVID-19’s impact on reproductive health services, and the effects of pre-eclampsia on birth weight. The list reflects her active involvement in studies addressing critical issues in women’s health.

Research Timeline:

Dr. Nakabembe’s research journey has evolved over the years, with notable milestones including her recent pursuit of a Ph.D. and leadership in the WoMANPOWER clinical trial. A comprehensive timeline would further illuminate the evolution of her research agenda and its alignment with advancements in maternal and child health.

In summary, Dr. Eve Nakabembe is a distinguished medical professional and researcher dedicated to advancing knowledge and improving healthcare outcomes for women and children. Her multidimensional career encompasses clinical practice, education, and groundbreaking research in the critical area of maternal vaccines.

Eve Nakabembe | Maternal Vaccines in HIV context | Women Researcher Award

You May Also Like